Clinical Trials Directory

Trials / Sponsors / Sunovion Respiratory Development Inc.

Sunovion Respiratory Development Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Soluti
Chronic Obstructive Pulmonary Disease (COPD)
Phase 42019-11-07
CompletedStudy to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow N
COPD
Phase 12015-10-01
CompletedEfficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)
COPD, Chronic Obstructive Pulmonary Disease
Phase 32015-02-01
CompletedEfficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD
COPD
Phase 32015-02-01
CompletedA Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Chronic Obstructive Pulmonary Disease (COPD)
Phase 32014-10-01
CompletedA Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
COPD
Phase 22014-01-01
CompletedA Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructiv
COPD
Phase 22012-10-01
CompletedStudy to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chron
Chronic Obstructive Pulmonary Disease
Phase 22011-08-01
CompletedAssessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate
Chronic Obstructive Pulmonary Disease
Phase 22010-07-01
CompletedAssessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate In
Chronic Obstructive Pulmonary Disease
Phase 22009-05-01